{"id":"W2763224818","doi":"10.1093/annonc/mdx371.079","title":"A phase 2 study of investigational TORC1/2 inhibitor TAK-228 and TAK-228 plus investigational PI3Kα-selective inhibitor TAK-117 vs everolimus in adults with advanced or metastatic clear-cell renal cell carcinoma (ccRCC) that has progressed on VEGF-targeted therapy","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine; Everolimus; Discovery and development of mTOR inhibitors; Investigational Drugs; Phases of clinical research; Oncology; Internal medicine; Pharmacology; PI3K/AKT/mTOR pathway; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001435908,0.001757078,0.003375196,0.0004416015,0.0004715781,0.00116398,0.001022914,0.001464305,0.004332292],"category_scores_gemma":[0.0008774215,0.0007814019,0.002482134,0.0004258237,0.001143018,0.001557799,0.0003420925,0.004562104,0.0007974972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001016451,"about_ca_system_score_gemma":0.001815664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00117609,"about_ca_topic_score_gemma":0.003358579,"domain_scores_codex":[0.9996246,0.0001223552,0.00001994218,0.00008979883,0.00002655608,0.0001167779],"domain_scores_gemma":[0.9993956,0.00009537807,0.00009016282,0.00006012197,0.00004506368,0.0003136272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9020115,0.05565729,0.00111624,0.0004900347,0.001211335,0.0001079415,0.0001327165,0.00101907,0.009918218,0.0002628536,0.00139147,0.02668146],"study_design_scores_gemma":[0.6484732,0.3447746,0.002569092,0.00002268436,0.0007063081,0.0001020734,0.00006258242,0.0005976413,0.001203033,0.0002032838,0.001259491,0.00002598885],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919147,0.002220175,0.0005538285,0.0005098851,0.0004123745,0.002074082,0.0008218506,0.00006502381,0.00142811],"genre_scores_gemma":[0.9855766,0.002456004,0.001882154,0.0009635617,0.0004255299,0.003738059,0.001706795,0.00003052748,0.003220766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004332292,"threshold_uncertainty_score":0.01449299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1153018011817261,"score_gpt":0.358595544223077,"score_spread":0.2432937430413509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}